GPCRs-Targeted Drug Discovery Summit Leaderboard
  • Thursday, May 7, 2026
  • About
  • Advertise
  • Subscribe
  • Contact

Pharma Journalist Pharma Journalist -

Obesity & Weight Loss Drug Development Summit Leaderboard
  • Home
  • News
  • Drug Research
  • Clinical Trials
  • Manufacturing
  • Information Technology
  • Packaging & Labeling
  • Diseases
  • Resources
    • Articles
    • Projects
    • Case Studies
    • Industry Reports
    • Interviews
    • White Papers
  • Events
  • Press Releases
Pharma Journalist
  • Home
  • Pharma Journalist
  • Page 137

Author

Pharma Journalist 8778 posts 0 comments

AbbVie Announces FDA and EMA Updates for Epcoritamab (EPKINLY/TEPKINLY) for the Treatment of…

Nov 29, 2023
AbbVie announced updates from the U.S. Food and Drug Administration (FDA) and European Medicines Agency (EMA) for epcoritamab, an investigational T-cell engaging bispecific antibody…
Read More...

Genelux Corporation Receives FDA Fast Track Designation for Olvi-Vec in Platinum…

Nov 28, 2023
Genelux Corporation announced that the United States Food and Drug Administration (FDA) has granted Fast Track designation for the development program of Olvi-Vec (olvimulogene…
Read More...

European Commission Approves KAFTRIO in Combination With Ivacaftor for the Treatment of Children…

Nov 24, 2023
Vertex Pharmaceuticals Incorporated announced that the European Commission has granted approval for the label expansion of KAFTRIO (ivacaftor/tezacaftor/elexacaftor) in a combination…
Read More...

SK bioscience and Hilleman Laboratories Announce Joint Development of Second-Generation Zaire Ebola…

Nov 23, 2023
SK bioscience, an innovative vaccine and biotech company committed to promoting human health from prevention to cure, announced that the company has entered into a development licensing…
Read More...

Boehringer Ingelheim receives approval for SENVELGO in Europe: the first oral liquid medication for…

Nov 23, 2023
Boehringer Ingelheim, a global leader in animal health, has received marketing authorization from the European Commission for SENVELGO (active ingredient: velagliflozin), marking a…
Read More...

Boehringer Ingelheim expands immuno-oncology portfolio with the acquisition of bacterial cancer…

Nov 23, 2023
Boehringer Ingelheim announced the acquisition of privately-held T3 Pharmaceuticals AG (“T3 Pharma”), a clinical stage Swiss biotech company, for an amount of up to 450 million CHF.…
Read More...

Vivodyne Announces $38 Million Seed Financing Led by Khosla Ventures to Develop Lab-Grown Human…

Nov 23, 2023
Vivodyne, a biotech that discovers and develops more effective drugs by testing them on lab-grown human organs, announced the close of $38 million in total seed financing, led by Khosla…
Read More...

FDA Grants Orphan Drug Designation to NeoImmuneTech’s NT-I7 for the Treatment of Acute…

Nov 22, 2023
NeoImmuneTech, Inc. announced that the U.S. Food and Drug Administration (FDA) has granted Orphan Drug Designation (ODD) for their investigational drug NT-I7 (efineptakin alfa)…
Read More...

Janssen Submits Supplemental Biologics License Application to U.S. FDA Seeking Approval of RYBREVANT…

Nov 22, 2023
The Janssen Pharmaceutical Companies of Johnson & Johnson announced the submission of a supplemental Biologics License Application (sBLA) to the U.S. Food and Drug Administration…
Read More...

Merck to Acquire Caraway Therapeutics, Inc.

Nov 22, 2023
Merck, known as MSD outside of the United States and Canada, and Caraway Therapeutics, Inc. announced that the companies have entered into a definitive agreement under which Merck,…
Read More...
Prev Next
2nd Operationalize: Expanded Access Programs Summit West
Neuropsychiatric Drug Development Summit
International Neoantigen Summit
Lab Ops & Facility Management for Biopharma West Summit
10th IPF Summit
Medical Device Software Development Summit
Liquid Biopsy for Precision Oncology Summit East Coast
ADC Linker & Conjugation Summit
GPCRs-Targeted Drug Discovery Summit
5th World ADC Summit South Korea
Extrahepatic Lipid-Based Nanoparticles Delivery Summit
World TPD & Induced Proximity Summit South Korea
Measuring Patient Engagement Summit
Investigative & Preclinical Toxicology Summit 2026
LEAP HR: Life Sciences West
Oligonucleotides for CNS Summit
R&D Procurement & Sourcing in Pharma Summit
In Vivo Cell Engineering & Gene Editing Summit
PFS & Injectable Drug Delivery West Coast
Obesity & Weight Loss Drug Development Summit
T-Cell Engager Therapeutics Summit
mRNA-Based Therapeutics Summit
World Bispecific & T-Cell Engager Summit South Korea
TCR-Based Therapies Summit
PFS & Injectable Drug Devices East Coast
5th ADC Analytical Development Summit
Nasal Formulation & Delivery Summit
Peptide-Based Therapeutics Summit 2026
ALS Drug Development Summit
About Us

Pharma Journalist

Pharma Journalist is a product of Kellen Media. Pharma Journalist is one of the leading website covering the need of global Pharmaceutical Industry.

Articles like latest news, trends, analysis, market report, press releases, whitepapers, case studies, etc. published on pharmajournalist.com helps Industry professionals and decision makers to stay on the top of this fast-paced industry.

Pharma Journalist aims of providing fast and informative articles to its readers and subscribers.

Recent Posts
  • MSD Completes $5.8 Billion Terns Pharmaceuticals Acquisition
  • Madrigal Licenses Gene Therapy Candidate for MASH Treatment
  • Citius Oncology Secures $36.5M to Boost LYMPHIR Launch
  • Latus Bio Raises $97 Million to Advance Gene Therapies
  • FDA Approves LANGLARA Biosimilar Insulin for Diabetes Treatment

Industry Reports

Amgen Acquires Dark Blue to Advance Novel AML Treatments

Takeda Expands Entyvio Options Through Halozyme Technology…

Inductive Bio Wins $21M to Build AI Drug Toxicity Models

Alkermes Boosts Offer to Acquire Avadel in Deal Worth Up to…

Novartis Completes Acquisition of Tourmaline Bio to…

Press Releases

Regeneron Goes All In on Radiopharma with $2.1B Telix Deal…

IQ MPS Leaders to Share Industry Progress on Advancing In…

4th ADC Linker & Conjugation Summit Announces 2026…

Turning Biophysical Data into Confident Drug Discovery…

Targeted LNP Delivery Beyond the Liver: The Challenges…

  • About
  • Advertise
  • Subscribe
  • Contact
© 2026 - Pharma Journalist. All Rights Reserved.
Pharma Journalist is a product of
Sign in

Welcome, Login to your account.

Forget password?
Sign in

Recover your password.

A password will be e-mailed to you.

We use cookies to ensure that we give you the best experience on our website. If you continue to use this site we will assume that you are happy with it.